Patents by Inventor Brendan Murphy
Brendan Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230397870Abstract: A health monitor, comprising: an electrode that includes a hydrogel composition comprising a first network that comprises at least two hydroxyl-bearing chains of a first polymer, the at least two hydroxyl-bearing polymer chains being crosslinked by crosslinks that comprise one or more boronic ester bonds; and at least one conductive additive dispersed within the composition, the electrode being configured for patient contact. Also provided are related methods.Type: ApplicationFiled: May 25, 2023Publication date: December 14, 2023Inventors: Flavia Vitale, Shu Yang, Mehrnaz Mojtabavi, Brendan Murphy, Mingtao Chen, Baohong Chen, Yuchong Gao
-
Patent number: 10837965Abstract: A method is provided for characterising and/or prognosing prostate cancer in a subject comprising measuring the level of at least one protein from a panel or at least one peptide thereof in a sample from the subject. The method may be used to determine the grade and stage of the prostate cancer. Also disclosed is a method for selecting a treatment for prostate cancer, together with corresponding methods of treatment. Systems and computing devices for performing the methods are also provided.Type: GrantFiled: December 19, 2014Date of Patent: November 17, 2020Assignee: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELANDInventors: Stephen Pennington, Brendan Murphy, William Watson
-
Publication number: 20170010269Abstract: A method is provided for characterising and/or prognosing prostate cancer in a subject comprising measuring the level of at least one protein from a panel or at least one peptide thereof in a sample from the subject. The method may be used to determine the grade and stage of the prostate cancer. Also disclosed is a method for selecting a treatment for prostate cancer, together with corresponding methods of treatment. Systems and computing devices for performing the methods are also provided.Type: ApplicationFiled: December 19, 2014Publication date: January 12, 2017Applicant: University College Dublin, National University of Ireland, DublinInventors: Stephen Pennington, Brendan Murphy, William Watson
-
Publication number: 20160321586Abstract: A method of automatically selecting tests for execution on a software product includes generating a cost model based on test performance history data that is based on results of past executions of a plurality of tests on the software product, wherein the cost model provides, for each test in the plurality of tests, a first expected monetary cost value associated with executing the test and a second expected monetary cost value associated with skipping execution of the test. The method includes automatically selecting tests in the plurality of tests for future execution based on the first and second expected monetary cost values.Type: ApplicationFiled: April 29, 2015Publication date: November 3, 2016Inventors: Kim Herzig, Jacek Czerwonka, Brendan Murphy, Michaela Greiler
-
Publication number: 20150192420Abstract: A follow-me application can be configured to generate a follow-me identifier (ID) that uniquely identifies a particular route traveled by a computing device executing the follow-me application. The follow-me application can also be configured to determine route data for the particular route traveled. The route data characterizes turn-by-turn directions to facilitate travel along the particular route by another computing device.Type: ApplicationFiled: January 7, 2015Publication date: July 9, 2015Applicant: TELECOMMUNICATION SYSTEMS, INC.Inventors: Brendan Murphy Watters, Gordon John Hines, Drew A. Morin, Victor Burton
-
Publication number: 20120143656Abstract: Embodiments of the invention are directed to group aggregation leveraging methods and systems for consumers to buy products from a broker. The broker offers a product to consumers for a first fixed price for a predetermined time period. Once a predetermined number of consumers commit to purchasing the product (i.e., reach a threshold), the consumers receive the same product at a second fixed price wherein the second fixed price is less than the first fixed price. Once the threshold is met, each committed consumer receives an alert from the broker that the consumer will receive the same product at the new reduced price (second fixed price). This process is repeated until the predetermined time period expires or inventory of the product is depleted. Consumers may leverage their collective group buying power by communicating to others that the product is available for the predetermined time period through social media or any other suitable means.Type: ApplicationFiled: May 31, 2011Publication date: June 7, 2012Applicant: TRIP ALERTZ, INC.Inventor: Brendan Murphy
-
Patent number: 7409604Abstract: Systems and methods for determining related node failures in a multi-node system use log data obtained from the nodes. This log data is processed in various ways to indicate clusters of nodes that experience related failures.Type: GrantFiled: December 19, 2003Date of Patent: August 5, 2008Assignee: Microsoft CorporationInventors: Brendan Murphy, Archana Ganapathi
-
Publication number: 20060146839Abstract: This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.Type: ApplicationFiled: September 5, 2003Publication date: July 6, 2006Inventors: Harlan Hurwitz, Stewart Kautsch, Brendan Murphy, Robert Pickles, Daniel Wobser
-
Patent number: 7070811Abstract: The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.Type: GrantFiled: July 26, 2005Date of Patent: July 4, 2006Assignee: Pfizer Inc.Inventors: Brendan Murphy, Steven W. Collier, Ernest Quan, Barbara A. Johnson
-
Publication number: 20060129484Abstract: This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.Type: ApplicationFiled: September 5, 2003Publication date: June 15, 2006Applicant: De La Rue International LimitedInventors: Harlan Hurwitz, Stewart Kautsch, Brendan Murphy, Robert Pickles, Daniel Wobser
-
Publication number: 20060112007Abstract: This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.Type: ApplicationFiled: September 5, 2003Publication date: May 25, 2006Applicant: De La Rue International LimitedInventors: Harlan Hurwitz, Stewart Kautsch, Brendan Murphy, Robert Pickles, Daniel Wobser
-
Publication number: 20060112006Abstract: This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media. This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.Type: ApplicationFiled: September 5, 2003Publication date: May 25, 2006Applicant: De La Rue International LimitedInventors: Harlan Hurwitz, Stewart Kautsch, Brendan Murphy, Robert Pickles, Daniel Wobser, Darren Taylor
-
Publication number: 20060106716Abstract: This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.Type: ApplicationFiled: September 5, 2003Publication date: May 18, 2006Inventors: Harlan Hurwitz, Stewart Kautsch, Brendan Murphy, Robert Pickles, Daniel Wobser
-
Publication number: 20060024363Abstract: The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.Type: ApplicationFiled: August 26, 2005Publication date: February 2, 2006Inventors: Brendan Murphy, Steven Collier, Ernest Quan, Barbara Johnson
-
Publication number: 20060024364Abstract: The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.Type: ApplicationFiled: August 26, 2005Publication date: February 2, 2006Inventors: Brendan Murphy, Steven Collier, Ernest Quan, Barbara Johnson
-
Publication number: 20050287209Abstract: The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.Type: ApplicationFiled: July 26, 2005Publication date: December 29, 2005Inventors: Brendan Murphy, Steven Collier, Ernest Quan, Barbara Johnson
-
Patent number: D774089Type: GrantFiled: February 25, 2015Date of Patent: December 13, 2016Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Bo-Woo Park, Brendan Murphy
-
Patent number: D788817Type: GrantFiled: January 2, 2015Date of Patent: June 6, 2017Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Rachel Kobetz, Brendan Murphy
-
Patent number: D878419Type: GrantFiled: October 21, 2018Date of Patent: March 17, 2020Assignee: Wells Fargo Bank, N.A.Inventor: Brendan Murphy
-
Patent number: D956429Type: GrantFiled: September 24, 2019Date of Patent: July 5, 2022Inventors: Brendan Murphy, Neil Murphy